SARAH EPLION: Open Payments
NPI 1427529130 · ASHLAND, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,293 in 120 payments from 32 companies in 2025. Trend: 2023 $903 · 2024 $3,113 · 2025 $2,293
Food & beverage: $2,133Education: $160
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 23 | $304 |
| E.R. Squibb & Sons, L.L.C. | 7 | $209 |
| PFIZER INC. | 12 | $182 |
| Pharmacosmos Therapeutics Inc. | 10 | $167 |
| AstraZeneca Pharmaceuticals LP | 7 | $157 |
| Merck Sharp & Dohme LLC | 6 | $123 |
| Astellas Pharma US Inc | 3 | $94 |
| Novartis Pharmaceuticals Corporation | 4 | $91 |
| Celgene Corporation | 5 | $89 |
| Daiichi Sankyo Inc. | 5 | $88 |
Products named: REBLOZYL, MONOFERRIC, RYBREVANT, KEYTRUDA, IBRANCE, ENHERTU, DARZALEX, OPDIVO.
Industry payments across KY — which companies pay providers there.
